Harvard Doctors Discover That a Common Drug Can “Turn On” Gene That Causes Cancer
Scientists propose a strategy for early intervention to enhance treatment outcomes. Hypomethylating agents (HMA) are currently used as a first-line treatment for individuals with myelodysplastic…